Escolar Documentos
Profissional Documentos
Cultura Documentos
conditions
September 21 and 28, 2016
Aisa G. Mendoza, MD DPSP
OBJECTIVES:
• Be familiar with some of the clinically
important epidermal, melanocytic and dermal
tumors
• Differentiate SCCA from BCCA
• Understand the pathophysiology of each
tumor and correlate it clinically
OUTLINE:
• Epidermal Tumors
– Seborrheic Keratosis
– Acrochordion
– Squamous Cell Carcinoma
– Basal Vcell Carcinoma
• Melanocytic Tumors
– Nevus
– Malignant Melanoma
• Dermal Tumors
– Dermatofibroma
– Dermatofibroma protuberans
SEBORRHEIC KERATOSIS
• Benign
• Pigmented
• Basal keratinocytic proliferation
• Trunk
• Laser-Trelat sign
LESION: round, flat, coin-like, waxy plaques
that vary in diameter; uniformly tan to dark
brown & usually have a velvety to granular
surface
MICRO: marked acanthosis of predominantly basaloid cells
with moderate papillomatosis and hyperkeratosis
- small keratin-filled cysts (horn cysts) and invaginations of
keratin into the main mass (invagination cysts)
Hyperkeratotic type
Acanthotic type
Reticulated or Adenoid
type
Acantholytic subtype
• Immunohistochem:
– Keratinocytes
• express Low Molecular Weight Keratin
• Deficient in High Molecular Weight Keratin
• Irritated seborrheic keratosis
– Squamous metaplasia is pronounced
– Misdiagnosed as basosquamous ca
– NOT related to HPV
• INSTEAD, HPV CAN BE IDENTIFIED IN THE SEBORRHEIC
KERATOSIS-LIKE LESIONS OF PATIENTS WITH
EPIDERMODYSPLASIA VERRUCIFORMIS AND THOSE
EXHIBITING BOWENOID CHANGES
• Treatment:
– Superficial curettage
– Freezing
FIBROEPITHELIAL POLYP
• A.K.A. acrochordon, squamous papilloma,
skin tag
• Generally detected as an incidental finding
in middle-aged and older individuals on
neck, trunk, face and intertriginous areas
• Often become more numerous or
prominent during pregnancy related to
hormonal stimulation
• LESION: soft, flesh-colored, bag-like tumor often
attached to the surrounding skin by a slender
stalk
MICRO: tumors consist of fibrovascular cores
covered by benign squamous epithelium
• Acquired (digital) fibrokeratoma
– Collagenous protrusions covered by hyperkeratotic
epidermis
– Usually seen around interphalangeal joints
Squamous cell carcinoma (SCCa)
• Actinic induced
• Induction of p53 mutation by ultraviolet light
• Sun exposure
• Lack of pigmentation in the skin
• Scca as a complication of the ff:
– BerEP4
• Negative :
– EMA
– CEA
– Involucrin
• Molecular
– Over expression of p53 protein
– Bcl-2 (differentiate with actinic keratosis)
• Genetic:
– Clonal chromosome abberation (numerical
changes +18, +9, +20, +7 and +5
– Loss of heterozygosity (9q22.3)
– Trisomy 6
Other microscopic type
• Superficial BCCA
– Arises in thin epidermis (trunk), sparse, fine hairs
– High recurrence
• Basosquamous (metatypical) CA
– Also contain atypical squamous cells
– More aggressive than conventional BCCA
– High proportion metastasize
• Granular basal cell CA
– Tumor cells with cytoplasmic granules
• Clear cell basal cell ca
– Prominent cytoplasmic vacuoles
– Signet ring configuration
• Fibroepithelial tumor / Pinkus’ tumor/
Fibroepithelioma
– Polypoid variant
– Occur at the back
– Abundant stroma
• Infundibulocytic basal cell ca
– Hair follicle differentation
Spread and metastasis
• Grow in slow, indolent fashion
• If untreated invade subcutaneous fat, skeletal
muscle and bone (“ulcus rodens”)
• Tumor in the face may invade the skull, nares,
orbit, temporal bone
• Distant metastasis is extraordinarily rare
– Regional LN, lungs, bones and liver
– Basosquamous type
• Treatment :
– Excision
– Curettage and desiccation
– Irradiation
• Recurrence :
– Radiation therapy
– Surgical re-excisison
– Mohs’ surgery
Benign and Malignant Tumors of
Melanocytes
• Nevus (pl. Nevi)
• Malignant Melanoma
Nevus (pl. Nevi)
• L. naevus, birthmark - any circumscribed
growth of the skin of congenital nature
• L. moles, a shapeless mass - localized benign
abnormality of the melanocytic system
• Melanocytic nevi – usually acquired
• Become clinically apparent after the first year
of life
• Appear 2nd to 6th years, nearly all by 20 years
• BRAF mutation
Nevus (pl. Nevi)
• Most common location?
• What is the distribution in the body?
• Head, neck, trunk? or
• Lower extremities?
• Different size, shape, degree of pigmentation
• More or less hairy
• Types are best classified accdg to location in
relation to the major epidermal and dermal
landmarks
Junctional nevus
• is restricted to the basal
portion of the
epidermis (‘junctional’
area)
• palms and soles
• Gross:
• Microscopic:
• Malignant melanomas
may arise from this
lesion
Compound Nevus
• it has both an epidermal
and a dermal component
• The percentage of nevi
with junctional changes
decreases as the age of the
patient increases
• amount of melanin
deposition is concentrated
in the superficial half of the
lesion
• lymphocytes and other
mononuclear cells may be
seen at the base of the
lesion
Intradermal Nevus
• all the melanocytes are in the
dermis
• Most common adult type of
nevus
• papillomatous,
pedunculated, or flat, and it
is often hairy
• Microscopic:
• Malignant melanomas
practically never arise from
intradermal nevi
Blue Nevus
• small and located in the head,
neck, or upper extremity
• an ill-defined deep dermal
proliferation of elongated and/or
dendritic dermal melanocytes
• Melanin pigment is usually
abundant
• junctional activity is consistently
absent
• GNAQ mutation, no BRAF
• Diff Dx: Benign Fibrous
Histiocytoma, DFSP, MM
Treatment
• Excision
• Definite indications
– appearance of a pigmented lesion in an adult
– chronic mechanical irritation of a nevus,
– appearance of any of the following changes in a
preexisting nevus:
• deepening of pigmentation or spread of the pigment
beyond the gross confines of the lesion
• appearance of flat areas of depigmentation within the
nevus,
• appearance of a red inflamed zone around the nevus
• rapid growth, ulceration, itching, oozing of serum, or
bleeding with trivial trauma.[
Malignant Melanoma
• Majority associated with sunlight exposure
• most are found in the head and neck area and
on the (lower extremities females)
• Whites with fair complexion, red hair , and a
tendency to burn or develop freckles after
exposure to sunlight
• Blacks-palms, soles, nail beds, or mucous
membranes
• SKIN, other sites (oral and anogenital
mucosal surfaces, esophagus, meninges &
eye)
– Men - on upper back
– Women -both the back and legs
• RISK FACTORS
– Fair skin (blond or red hair, light-colored eyes, freckle
or sunburn easily)
– History of blistering sunburn
– Excessive UV light exposure (sun & tanning beds)
– Living closer to the equator or at a higher elevation
– Having many moles or unusual moles (>50 or unusual
mole >5mm)
– Family history of melanoma
– Weakened immune system
• Immunohistochemical Features:
positive for
– HMB-45
– vimentin
– S-100
– Melan-A
– tyrosinase
• Molecular genetic factors: genetic
abnormalities detected in melanoma
include:
– CDKN2A and PTEN inactivation
– RAS mutation
– BRAF mutation
Clark Model of Tumor Progression
Pathogenesis
Dysplastic Nevus
• Precursor of melanoma
• Dysplastic nevus syndrome: probability that a
person will develop melanoma is over 50% by
age 60 and at-risk individuals sometimes develop
several melanomas at different sites
Dysplastic Nevus
• larger than most acquired nevi (often >5 mm across)
• flat macules, slightly raised plaques
• variability in pigmentation (variegation)
• borders that are irregular in contour
• occur on non-sun-exposed as well as on sun-
exposed body surfaces
• probability of developing melanoma is 56% at age
59 years
LESION: flat macules, slightly rased plaques
with a “pebbly” surface, or target-like lesions
with a darker raised center and irregular flat
periphery
MICRO: Nevus cell nests within the epidermis may be enlarged
and often fuse or coalescence with adjacent nests
Pathogenesis
• Dysplastic nevus syndrome is inherited in an
autosomal dominant pattern.
• Several mutated genes have been discovered
in affected families, including CDKN2A on
chromosome 9p21 and CDK4 (cyclin-
dependent kinase 4) on chromosome 12q14,
both of which are also associated with
familial forms of melanoma
Dysplastic Nevus Radial Growth-Phase Melanoma
May be <6mm in diameter, not often >10mm Usually >6mm, often much >10mm
Uniformly elongated narrow, delicate rete Irregularly thickened epidermis, often with
ridges effaced rete ridges
No alteration of stratum corneum May be hyperkeratotic
Nests predominate over single cells in the Single cell predominate except in late lesion
epidermis
Little or no pagetoid spread of lesional cells Usually obvious pagetoid spread into
into epidermis epidermis, extending to S. corneum
Scattered atypical epithelioid cells with dusty Epithelioid cells with dusty pigment, nucleoli,
melanin pigment, nucleoli, anisokaryosis anisokaryosis predominate (uniform atypia)
(random atypia)
Most cells are not atypical Most cells are atypical
Clark Level
• Level I: confined to the epidermis (top-most layer of skin);
called "in situ" melanoma; 100% cure rate at this stage
• Level II: invasion of the papillary (upper) dermis
• Level III: filling of the papillary dermis, but no extension in
to the reticular (lower) dermis
• Level IV: invasion of the reticular dermis
• Level V: invasion of the deep, subcutaneous tissue
AJCC 2010 Staging
AJCC 2010 Staging
Spread and Metastases
• melanoma spreads by growing along the
dermoepidermal junction and upper dermis
and later by invading the deep dermis and
eventually the subcutis and deeper structures
• Metastases in regional lymph nodes are
common even if the nodes appear clinically
negative
• Distant metastases-liver, lungs,
gastrointestinal tract, bone, and central
nervous system but can occur anywhere,
including within other tumors
Treatment
• wide excision of the primary lesion (atleast 3.0
cm margin) with radical lymph node dissection
• Radiation therapy-Hutchinson freckle
(alternative)
• radiation therapy, chemotherapy, and
immunotherapy are ineffective in invasive or
metastatic melanoma
• Dacarbazine-drug of choice in disseminated
melanoma
• interleukin, biochemotherapy, and interferon
have given good results, but only in a small
percentage of patients
Prognostic Factors
• Tumor stage-the most important prognostic
parameter
• Level of invasion and tumor thickness (Clark
and Breslow)
• Shape of the lesion-plypoid is poorer
• Sex-the 5 year survival rate was 50.5% for
males and 70.5% for females
• Age-younger is better in MALES but not in
females
Prognostic Factors
• Anatomic location-scalp, mandibular area,
midline of trunk, upper medial thighs, hands,
feet, popliteal fossae, and genitalia, ungual